Table 6. The performance of models developed using different machine techniques based on RCSP-set-Weka-Hall (38 genes) selected from Weka.
Technique | Dataset | Performance Measures |
||||
---|---|---|---|---|---|---|
Sensitivity | Specificity | Accuracy (%) | MCC | ROC | ||
RF | Training | 75.10 | 78.66 | 76.50 | 0.53 | 0.84 |
Validation | 67.19 | 78.57 | 71.70 | 0.45 | 0.75 | |
Naive Bayes | Training | 79.84 | 71.34 | 76.50 | 0.51 | 0.83 |
Validation | 75.00 | 66.67 | 71.70 | 0.41 | 0.79 | |
SMO | Training | 85.77 | 66.46 | 78.18 | 0.54 | 0.76 |
Validation | 82.81 | 59.52 | 73.58 | 0.44 | 0.71 | |
J48 | Training | 71.54 | 61.59 | 67.63 | 0.33 | 0.69 |
Validation | 68.75 | 71.43 | 69.81 | 0.39 | 0.68 | |
SVM | Training | 80.24 | 73.78 | 77.70 | 0.54 | 0.83 |
Validation | 73.44 | 71.43 | 72.64 | 0.44 | 0.78 |
These genes are specifically involved in cancer hallmark biological processes (Cancer hallmark GO terms). The model was evaluated using 10-fold cross validation on training dataset as well as on independent external validation dataset.